USPTO 2015–2025 USPTO PatentsView Foreign Corporation

KARDIUM INC.

USPTO PatentsView assignee record — 146 granted patents across 8 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

146
Total patents granted
8
CPC technology areas
31.0
Avg claims per patent
+39%
5-year filing velocity

Portfolio overview

KARDIUM INC. has been granted 146 US utility patents between 2015 and 2025, placing KARDIUM INC. at rank #2,661 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 31.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, KARDIUM INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 85 grants, compared with 61 in the 2015–2019 window — a +39% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. KARDIUM INC.'s 31.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KARDIUM INC. against peers pursuing similar technology classes.

How does KARDIUM compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows KARDIUM holds 146 patents — placing it at rank #2,661 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

510152025 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
KARDIUM INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 13 8.9%
2016 11 7.5%
2017 15 10.3%
2018 12 8.2%
2019 10 6.8%
2020 22 15.1%
2021 11 7.5%
2022 15 10.3%
2023 14 9.6%
2024 10 6.8%
2025 13 8.9%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Complex
Velocity Growing

Where it ranks

Overall rank by patents

#2,661

Across all tracked assignees

Innovation Score

48.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does KARDIUM INC. hold?
KARDIUM INC. holds 146 US granted patents filed between 2015 and 2025, spanning 8 technology areas.
What is KARDIUM INC.'s Innovation Score?
KARDIUM INC. has an Innovation Score of 48.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does KARDIUM INC. focus on?
KARDIUM INC.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 135 patents. The company has filed patents in 8 CPC subclasses total.
Is KARDIUM INC.'s patent filing rate increasing or decreasing?
KARDIUM INC.'s recent filing velocity is +39% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for KARDIUM INC.'s patents?
KARDIUM INC.'s patents average 31.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the KARDIUM INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope